Enterprise Europe Network

Belgium company specialised in diagnostic kits in the field of musculoskeletal disorders and age-related diseases based on innovative biomarkers is looking for distribution agreements

Country of origin:
Country: 
BELGIUM
Opportunity:
External Id: 
BOBE20190214001
Published
16/04/2019
Last update
16/06/2019
Expiration date
16/06/2020

Keywords

Partner keyword: 
Clinical Research, Trials
Diagnostics, Diagnosis
Environmental Medicine, Social Medicine, Sports Medicine
Gerontology and Geriatrics
Medical Technology / Biomedical Engineering
Cellular and Molecular Biology
In-vitro diagnostics
Molecular diagnosis
Geriatrics
EXPRESS YOUR INTEREST

Summary

Summary: 
The Belgian clinical research organisation is specialised in innovative biomarker-based solutions to manage musculoskeletal and age-related chronicle diseases such as osteoarthritis, musculoskeletal disorders, etc. It offers diagnostic kits along with technical and scientific support, and is willing to identify new partners under distribution agreements.

Description

Description: 

The Belgian SME, created in 2010, is a clinical research organisation (CRO) specialised in developing solutions based on specific and innovative biomarkers in the context of precision medicine and personalized healthcare of musculoskeletal disorders & age-related diseases (osteoarthritis, inflammation, cartilage degradation, bone metabolism, metabolic disorders, cardiovascular, sarcopenia...)

Through the design and development of innovative biomarker-based solutions, its mission is to address unmet needs for product development in musculoskeletal disorders and age-related diseases.

From preclinical studies to postmarketing clinical trials, the SME provides scientific expertise, research and development support services, and tools for the evaluation of clinical, structural, and biological impact of a compound on musculoskeletal health.

Along with its diagnostic kits, the company offers technical and scientific support to its clients. These clients are in general researchers, businesses (biotech food, nutraceutical, pharmaceuticals, other clinical research organisations), local distributors, research centers and universities.

The company works at increasing its presence on the international market and access new markets, offering its specific added-value in terms of expertise and support.
In this perspective it is aiming at developing long-term partnerships under distribution agreement with partners such as companies in the pharmaceutical sector or biotechnological agrofood sector, or local distributors.
It is also willing to develop partnerships under distribution agreements with researchers, research centers or universities.

Advantages & innovations

Cooperation plus value: 
- The SME does not just provide the diagnostic kits but offers together with the kits a highly qualified technical and scientific support to the client - service which is not provided by major key players in the sector. They do not act only as kits providers but accompany the clients in the selection of the right parameters and offer then a strong technical and scientific support thanks to their expertise in the field. - Certifications and high quality standards : the SME is ISO9001 & ISO13485 certified for all their activities and they follow international guidelines: Good Clinical Practice (GCP), Good Clinical Laboratory Practice (GCLP), , International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)…High quality standards and ethics are in the heart of their activities: from ISO certifications to international guidelines, from preclinical to manufacturing, skilfully integrated by the Quality Assurance Officer (QAO). - Tailormade, all-in-one solutions : the SME works side by side with their clients in order to develop and propose the most relevant solution for their needs. They can offer all-in-one solutions (for example from preclinical to post-marketing studies) or act like a subcontractor for one specific need. - Early detection of treatment efficiency, improved understanding of disease development : the SME’s biomarkers allow to detect the disease earlier and to analyse the effect of a compound or a treatment in the disease development.

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
The Belgian clinical research organisation (CRO) is willing to develop long-term partnerships under the form of distribution agreements with : - companies active in the sectors of pharmaceutics, nutraceutical, biotechnological, local distributors or other CROs; the SME would here reach new markets for the distribution of its diagnostic kits. - researchers, research centers or universities, conducting researches in the field of musculoskeletal disorders, age-related diseases, etc. The Belgian SME would offer its range of diagnostic kits together with technical and scientific support to this category of clients.

Type and size

Cooperation task: 
SME 11-50,University,Inventor,R&D Institution,SME <10,>500 MNE,251-500,SME 51-250,>500

pic_pod.png

Example of diagnostic kit